CAMP·13463J101·US·equity·Healthcare - Biotechnology-Activist
CAMP (CAMP4 THERAPEUTICS CORP) is held by 26 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($27.9M), FMR LLC ($21.8M), BALYASNY ASSET MANAGEMENT L.P. ($11.6M). Net institutional sentiment: Mixed.
See how CAMP's score breaks down across 4 SEC sources
Showing 1-20 of 33
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer